home / stock / txmd / txmd news


TXMD News and Press, TherapeuticsMD Inc. From 07/15/22

Stock Information

Company Name: TherapeuticsMD Inc.
Stock Symbol: TXMD
Market: NASDAQ
Website: therapeuticsmd.com

Menu

TXMD TXMD Quote TXMD Short TXMD News TXMD Articles TXMD Message Board
Get TXMD Alerts

News, Short Squeeze, Breakout and More Instantly...

TXMD - Biotech Stocks Outperformance Factors - Will they Continue?

The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...

TXMD - Biomerica, Clene top healthcare gainers; ContraFect, Novavax lead losers' pack

Gainers: Biomerica ( BMRA ) +23% . Clene ( CLNN ) +22% . Gossamer Bio ( GOSS ) +11% . Revelation Biosciences ( REVB ) +10% . Nutriband ( NTRB ) +7% . Losers: ContraFect ( CFRX ) -81% . Novavax ( NVAX ) -1...

TXMD - Telefonaktiebolaget LM Ericsson, Harmony Gold Mining, BELLUS Health among premarket losers' pack

ContraFect ( CFRX ) -77% as data safety board recommends ending co's DISRUPT trial . BELLUS Health ( BLU ) -10% on pricing $153M stock offering in Canada, U.S. Telefonaktiebolaget LM Ericsson ( ERIC ) -9% on Q2 earnings release . Therape...

TXMD - XORTX Therapeutics leads healthcare gainers, Humanigen and Atara Biotherapeutics among losers

Gainers: XORTX Therapeutics ( XRTX ) +39% . Gossamer Bio ( GOSS ) +24% . Rhythm Pharmaceuticals ( RYTM ) +23% . Apollo Endosurgery ( APEN ) +18% . Tyra Biosciences ( TYRA ) +15% . Losers: Humanigen ( HGEN ) -80% . Atara Biotherap...

TXMD - Fastenal, Unity Software, MSP Recovery among premarket losers' pack

Humanigen HGEN -68% as trial for COVID-19 therapy fails . Atara Biotherapeutics ATRA -46% on interim analysis of phase 2 study for multiple sclerosis candidate. TherapeuticsMD TXMD -41% as merger agreement ends . Helius Medical Technologies ( HSDT...

TXMD - TherapeuticsMD plunges 42% as merger agreement ends

The shares of TherapeuticsMD ( NASDAQ: TXMD ) dropped ~42% in the pre-market Wednesday after the women’s healthcare company announced the termination of its merger agreement with an Athene Merger, an affiliate of the private equity firm EW Healthcare Partners. T...

TXMD - TherapeuticsMD Announces Expiration of Tender Offer

Company anticipates termination of Merger Agreement with EW Healthcare Partners TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TXMD” or the “Company”) an innovative, leading women’s healthcare company, announced today that Athene Merger, Inc., an a...

TXMD - Forensic Value Stock Selections: Top Positive And Negative Forensic Mid-Year 2022 Picks

These July sample selections are the current top positive/negative forensic stocks out of 8,000 stocks based on combined scores from four top forensic algorithms. The January Positive Forensic portfolio is beating the S&P 500 by +1.59% YTD. The Negative portfolio is beating by +13...

TXMD - Inspira, Cano top healthcare gainers; Applied Molecular, HTG Molecular lead losers' pack

Gainers: Inspira Technologies Oxy ( IINN ) +98% . Cano Health CANO +18% . Veru VERU +16% . Amylyx Pharmaceuticals ( AMLX ) +13% . Equillium ( EQ ) +12% . Losers: Applied Molecular Transport AMTI -26% . HTG Molecular D...

TXMD - TherapeuticsMD risks bankruptcy as EW Healthcare extends tender offer for acquisition

Private equity firm EW Healthcare Partners announced on Wednesday that its affiliate Athene Merger extended the tender offer to acquire the women’s healthcare company TherapeuticsMD ( NASDAQ: TXMD ). Without a successful closure of the transaction, TherapeuticsMD ( ...

Previous 10 Next 10